All COPD participants were stratified according to the levels of α-klotho (Q1: <687 pg./mL; Q2: 687–900 pg./mL; Q3: ≥900 pg./mL), and clinical characteristics were compared. The gene discussed is KL; the disease is chronic obstructive pulmonary disease.